UNH

UnitedHealth Group Inc. UNH logo

NYSE Healthcare

$267.73

+6.19 (+2.36%)

Updated: 3/31/2026, 4:00:01 PM

Open

$263.00

High

$268.33

Low

$260.25

Prev Close

$261.79

Volume

3.51M

Price History

Why Is UNH ▲ Up Today?

+2.36%

Full AI analysis generates after market close. Showing live price data.

Mar 31 ▲ +2.4% UNH Rises Amidst Sector Gains and AI Integration News

Mar 30 ▲ +0.8% UNH Up Slightly Amidst Sector Gains

Mar 27 ▼ -3.6% UNH Down Amidst Sector Weakness and Regulatory Concerns

Mar 26 ▼ -0.9% UNH dips slightly amid sector rotation, down -0.8982%

Mar 25 ▼ -0.9% UNH down slightly amid sector outperformance, regulatory scrutiny

Mar 24 ▲ +1.1% UNH Rises Slightly Amidst Sector Gains

Mar 23 ▼ -2.2% UNH Declines Amidst Analyst Downgrades and Market Aversion

Mar 20 ▼ -1.5% UNH down amid broader sector weakness

Mar 19 ▼ -1.3% UNH dips amid broader defensive sector concerns

Mar 18 ▼ -1.5% UNH down slightly amid broader sector weakness

Mar 17 ▲ +0.7% UNH Gains Slightly Amidst Sector Weakness

Mar 16 ▲ +1.4% UNH Up Slightly Amidst Positive Sector Sentiment

Mar 13 ▲ +1.6% UNH up 1.61% amid mixed healthcare sector

Mar 12 ▼ -2.8% UNH down on sector concerns, despite positive signals

Mar 11 ▲ +1.1% UNH up 1.12% amid mixed sector performance

Mar 10 ▼ -1.0% UNH dips slightly amid sector concerns, down 0.96%

Mar 9 ▼ -0.6% UNH dips slightly amid mixed sector performance

Mar 6 ▼ -1.0% UNH down slightly amid sector gains, regulatory concerns linger

Mar 5 ▼ -0.9% UNH down slightly amid sector weakness, -0.9008%

Mar 4 ▲ +0.6% UNH Gains Slightly Amidst Sector Growth

Mar 3 ▼ -2.1% UNH Down Amidst Sector Weakness and Scrutiny

Mar 2 ▲ +0.1% UNH edges higher amid sector weakness, healthcare analytics growth

Feb 27 ▲ +2.0% UNH Gains Amidst Mixed News, Sector Shows Strength

Feb 26 ▲ +0.9% UnitedHealth Group (UNH) Gains Slightly Amidst Sector Weakness

Feb 25 ▲ +3.5% UnitedHealth Group (UNH) Rises on Dividend Announcement

Feb 24 ▼ -3.0% UnitedHealth Group (UNH) Drops on Profitability Concerns

Feb 23 ▼ -2.6% UNH Declines Amidst Sector Gains, Revenue Concerns

Feb 20 ▼ -0.3% UNH Down Slightly Amidst Sector Weakness

Feb 19 ▲ +0.5% UnitedHealth (UNH) Up Slightly Despite Negative Sector Sentiment

Feb 18 ▼ -0.4% UNH Down Slightly Amid Sector Weakness

Financial Highlights

Income Statement

Revenue

$435.16B

Gross Profit

$384.72B

88.4% margin

Operating Income

$26.36B

6.1% margin

Net Income

$18.37B

4.2% margin

EPS (Diluted)

$19.19

Balance Sheet

Total Assets

$315.27B

Total Liabilities

$209.46B

Stockholders' Equity

$101.57B

Cash Flow

Operating Cash Flow

$20.96B

Investing Activities

-$7.19B

Net Cash Flow

-$5.20B

Highly Regarded Analysis

Updated Apr 10, 2026 • Refreshes daily

Rating

Highly Regarded

Risk

Medium

Target

$363.42

Type

Standard

Executive Summary

UnitedHealth Group (UNH) is a leading health insurer and services company. Recent challenges, including increased medical costs and regulatory scrutiny, have impacted the stock price, but analysts remain optimistic about a recovery driven by margin improvements and growth in the Optum segment. The company is focusing on higher-quality membership and stricter pricing discipline.

Bull Case

The bull case centers on margin recovery through repricing, benefit cuts, and shedding unprofitable plans. Growth in the Optum segment, driven by AI and vertical integration, is also a key factor. Analysts anticipate earnings growth across Optum, with margin improvements.

Bear Case

The bear case focuses on potential MCR re-acceleration, regulatory and antitrust risks, and declining membership. Scrutiny surrounding Medicare Advantage billing practices and potential DOJ investigations also pose risks.

Technical Outlook

The stock is currently trading near its 52-week low, indicating a potential buying opportunity. The stock price has shown mixed signals recently.

Fundamental Health

UNH has a market capitalization of $278.57B and a P/E ratio of 23.28. The company's debt-to-equity ratio is 77.1%. Revenue for 2025 was $447.57 billion, a 12% increase year-over-year. However, operating income fell 41% to $19.0 billion in 2025 due to higher medical costs.

Key Catalysts

Medicare Advantage rate finalization
Optum Health margin recovery
Potential M&A acceleration

Sources

substack.com simplywall.st ebc.com simplywall.st robinhood.com tradingview.com simplywall.st fool.com seekingalpha.com trefis.com public.com tikr.com barchart.com reddit.com

This analysis was conducted by Highly Regarded's proprietary market analysis engine. It is not financial advice. Always do your own research and consult a financial advisor before making investment decisions.